How common is lung cancer in non-smokers?

Between 12-14% of lung cancer diagnoses are in people who have never smoked. This type, often adenocarcinoma, is particularly concerning as it's increasingly diagnosed in younger, healthy individuals, especially women.

What does 'stage 4 lung cancer' mean?

Stage 4 lung cancer means the cancer has spread from its original site of origin to other parts of the body. In Dr. Hallberg's case, it had spread to her brain.

What are EGFR and ALK mutations in lung cancer?

EGFR (Epidermal Growth Factor Receptor) and ALK (Anaplastic Lymphoma Kinase) are specific mutations found in non-small cell lung cancer. These mutations allow for targeted therapies like tyrosine kinase inhibitors.

How did Dr. Hallberg cope with her diagnosis as a mother?

Dr. Hallberg experienced overwhelming grief contemplating her children's future and her inability to be fully present for them. She chose to be honest with them and focus on living to see her youngest graduate.

What is the typical survival rate for stage 4 lung cancer?

The median survival for stage 4 lung cancer is generally 12 months or less, and sometimes even as low as eight months, depending on the specific type of cancer.

What treatment strategies did Dr. Hallberg pursue?

Dr. Hallberg underwent emergency brain surgery, radiation, targeted therapies (TKIs), various chemotherapy regimens including cisplatin and gemcitabine, and anti-estrogen therapy, often exploring less conventional or aggressive approaches.

What is atypical hemolytic uremic syndrome?

Atypical hemolytic uremic syndrome is a rare, severe condition causing multi-organ failure, often as a complication of chemotherapy like Gemcitabine. It has a high mortality rate and can lead to permanent dialysis.

What challenges did Dr. Hallberg face with recurrence?

Despite her resources and advocacy, Dr. Hallberg experienced a four-month delay in starting treatment for her cancer recurrence, highlighting systemic issues and the critical need for patient advocacy, especially after initial diagnosis.

How has cancer changed Dr. Hallberg's perspective on time and life?

While cancer is a difficult experience she's still angry about, Dr. Hallberg doesn't feel it gave her a completely new perspective, as she already cherished her life and family. However, it has intensified her focus on health equity and advocacy.

What is Dr. Hallberg's current approach to spending her time?

She prioritizes her children but also continues her work in diabetes and cancer advocacy, driven by a desire for health equity. She manages expectations by saying she's 'doing okay' rather than 'great' or 'good'.

Key Moments

Dr. Sarah Hallberg: A personal journey through cancer | The Peter Attia Drive Podcast

Peter Attia MD

People & Blogs5 min read71 min video

May 20, 2021|54,649 views|2,022|337

Dr. Sarah Hallberg sarah hallberg cancer journey cancer story cancer diagnosis cancer diagnosis story

Save to Pod

Key Moments

TL;DR

Dr. Sarah Hallberg's unexpected stage 4 lung cancer diagnosis and her fight for life, health equity, and purpose.

Key Insights

Non-smokers, particularly young women, are increasingly diagnosed with specific types of lung cancer (adenocarcinoma, EGFR/ALK-positive), a trend not fully understood or investigated.

Early diagnosis and aggressive, multi-faceted treatment, including targeted therapies and chemotherapy, are crucial for managing advanced lung cancer.

The psychological toll of a cancer diagnosis includes stages of grief, denial, and the profound impact on family, especially children.

Navigating the healthcare system as a cancer patient highlights significant disparities and the critical need for health equity, even for those with privilege.

Finding purpose and maintaining agency, like challenging conventional treatment timelines and prioritizing family, are vital for coping with a terminal illness.

Acceptance of life's altered trajectory, while grieving lost dreams, is a key component of adapting to a cancer diagnosis.

AN UNEXPECTED DIAGNOSIS AMIDST A HEALTHY LIFESTYLE

Dr. Sarah Hallberg, known for her dedication to health and wellness, including marathon running and healthy eating, faced a shocking diagnosis of stage 4 lung cancer in June 2017. Despite never smoking and maintaining a rigorous fitness regimen, she experienced a sudden inability to speak, leading to emergency room admission. Imaging revealed a large brain tumor and multiple tumors in her chest, confirming non-small cell lung cancer, specifically adenocarcinoma, a type often found in non-smokers. This diagnosis, occurring just after a pivotal professional meeting, blindsided her and her family, given her seemingly perfect health.

FACING MORTALITY AND THE STAGES OF GRIEF

The immediate aftermath of the diagnosis plunged Dr. Hallberg into a profound journey through the stages of grief and denial. Faced with the grim statistics of stage 4 lung cancer, her initial thought was to seek physician-assisted suicide in Oregon, fearing the suffering for herself and her family. The realization of the potential impact on her children, aged 7, 12, and 14, brought an overwhelming grief. The denial manifested in her pushing herself physically shortly after brain surgery, attempting to prove her health, while grappling with the stark reality of her prognosis.

THE CHALLENGE OF NON-SMOKER LUNG CANCER

Dr. Hallberg highlights the alarming rise of lung cancer in non-smokers, particularly women, attributing it to specific mutations like EGFR and ALK. This demographic, often healthy and fit, defies traditional assumptions about lung cancer. She notes the lack of extensive research into the causes for this specific group, unlike the well-studied links to insulin resistance in other cancers. The disparity in attention and research for this growing subset of lung cancer patients underscores a critical gap in understanding and treatment.

AGGRESSIVE TREATMENT AND THE QUEST FOR CONTROL

Refusing to be a 'sitting duck,' Dr. Hallberg embarked on an aggressive treatment plan. Following emergency brain surgery and radiation, she pursued targeted therapies like tyrosine kinase inhibitors (TKIs). When these treatments showed limitations, she explored chemotherapy and anti-estrogen therapy, adapting her approach to combat potential mutations. This proactive strategy involved seeking surgeons for tumor removal and radiation oncologists willing to manage her condition, demonstrating a fierce determination to control her disease progression.

NAVIGATING HEALTHCARE DISPARITIES AND HEALTH EQUITY

Her experience as a cancer patient illuminated the stark realities of health equity. Despite her privileged position as a physician with resources and insurance, she faced significant delays in accessing clinical trials, estimated at four months for her recurrence. This prompted her realization that many others, lacking her advantages, likely succumb during such delays. She realized that her fight extended beyond personal survival to advocating for systemic change, ensuring equitable access to timely and effective cancer care for all patients.

REDEFINING PURPOSE AND EMBRACING LIFE'S CURRENCY

Dr. Hallberg recounts moments of existential reflection, particularly a conversation with her son about her work, which solidified her commitment to continuing her impactful career. This led to prioritizing her time, balancing family, her established work in diabetes, and her burgeoning role as a cancer advocate. While acknowledging the difficulties and the loss of her pre-cancer life, she emphasizes embracing the present, finding strength in adversity, and channeling her experiences into advocating for health equity, transforming her anger into a powerful force for change.

MANAGING SEQUELAE AND FIGHTING FOR TIME

Her treatment journey was arduous, including a severe complication from chemotherapy (gemcitabine-induced atypical hemolytic uremic syndrome) that led to multi-organ failure. Miraculously, she recovered, though it removed certain treatment options. Genetic testing later revealed a mutation that prevented gemcitabine breakdown, explaining the severe reaction. Despite these setbacks and a recurrence in September 2020, she continued to fight, driven by her goal of securing at least 11 years of life to see her youngest child graduate. This pursuit of time became her driving force.

THE PSYCHOLOGICAL IMPACT AND UNEXPECTED RECURRENCE

The cancer's return in September 2020, even with her constant advocacy and privileged access to care, highlighted systemic failures, particularly the lack of streamlined support upon recurrence. The four-month delay in accessing a clinical trial was agonizing. She experienced severe bronchial compression, impacting her basic mobility. This recurrence intensified her commitment to health equity, emphasizing how crucial it is for others facing similar challenges to have robust support systems, especially when their cancer returns.

FINDING ACCEPTANCE AND CONTINUING TO LIVE

Dr. Hallberg shares the difficult process of accepting a life path different from her original dreams, such as retiring to a farm. While acknowledging the grief for lost temporal possibilities and her former self, she emphasizes the choice to live fully, rather than succumb to self-pity. Her legacy is defined not by her duration of life, but by her resilience, her advocacy for patients, and her determination to improve health equity, ensuring future patients have better outcomes and support.

Mentioned in This Episode

●Companies

●Organizations

●Concepts

●People Referenced

Navigating a Cancer Diagnosis: Key Takeaways

Practical takeaways from this episode

Do This

Prioritize open communication with children, even when difficult.

Focus on controlling what you can, such as treatment timing and aggressiveness.

When facing uncertainty, seek out diverse medical opinions and advocate fiercely for yourself.

Reframe anger and grief into actionable steps towards positive change.

Recognize the importance of health equity and shared decision-making in healthcare.

Avoid This

Don't succumb to denial or the urge to 'prove' you're not sick immediately after a severe diagnosis.

Don't passively wait for cancer to progress; actively seek proactive treatment strategies.

Don't be afraid to question conventional treatment dogma or standard protocols.

Don't underestimate the impact of cancer treatment side effects, but learn to manage them pragmatically.

Don't accept the system's shortcomings, especially concerning cancer recurrence and the need for re-advocacy.

Common Questions

Dr. Sarah Hallberg was diagnosed with stage 4 lung cancer, which had spread to her brain and chest. Initially, she was experiencing stroke-like symptoms due to a brain tumor.

Topics

Health & Longevity Mindset & Self-Improvement Health Equity Medical Decision-making Cancer Treatment Patient Advocacy Medicine & Clinical Lung Cancer Genomic Medicine Grief And Coping

Mentioned in this video

People

Jeff Polek

Co-founder of Virta Health.

Steve Finney

Co-founder of Virta Health.

Drugs & Medications

Gemcitabine

A chemotherapy drug (also known as Gemzar) typically used for pancreatic cancer, which Dr. Hallberg experienced severe side effects from.

Tyrosine Kinase Inhibitors

A class of targeted therapy medications used to treat EGFR-driven lung cancer, which can be highly effective but resistance can develop.

Tagrisso

A TKI medication prescribed to Dr. Hallberg for her lung cancer.

Fulvestrant

A medication used in combination with other drugs for anti-estrogen therapy.

Companies

Virta Health

A company focused on remotely treating patients with type 2 diabetes, co-founded by Steve Finney and Jeff Polek.

Locations

Oregon

Dr. Hallberg initially wanted to move to Oregon due to its physician-assisted suicide laws, reflecting her despair at the diagnosis.

Concepts

Atypical Hemolytic Uremic Syndrome

A rare and severe complication Dr. Hallberg developed, likely due to Gemcitabine, characterized by multi-organ failure and high mortality.

Supplements

Cisplatin

A chemotherapy drug used to treat Dr. Hallberg's cancer, which she tolerated well.

Lupron

A medication used in combination with other drugs for anti-estrogen therapy.

Organizations

Aspen Institute

An organization that brings together thinkers from various disciplines, which Dr. Hallberg was selected to represent as a Health Innovator Fellow.

Found this useful? Build your knowledge library

Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.

Try Summify free